Reported about 22 hours ago
Eli Lilly has partnered with Nvidia to create a supercomputer aimed at accelerating drug discovery and development processes. This collaboration will enable Lilly's scientists to train AI models on vast amounts of experimental data, enhancing their drug discovery efforts. The AI models will be accessible through Lilly TuneLab, a platform that ensures privacy while allowing biotech companies to utilize Lilly's research. With the supercomputer, Lilly also looks to streamline drug development cycles and explore further applications in manufacturing and medical imaging.
Source: YAHOO